News · 18 November 2026

Biotech Artiva shuts down cell therapy work after two trial deaths

18 November 2026 · San Diego, California · Health · Business · US

Biotech Artiva shuts down cell therapy work after two trial deaths
Picture: STATNEWS · STATNEWS syndication feed

Artiva Biotherapeutics is ending work on its cell therapy for autoimmune diseases after two trial patients died. One died from a brain complication linked to a chemotherapy given before treatment. The other died suddenly about two months after treatment. The San Diego company says neither death was caused by its therapy. It plans to lay off 94% of its staff.

Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.

Also on 18 November 2026